- 1) Redwood, W. R. and Colvin, M., Transport of melphalan by sensitive and resistant L1210 cells. Cancer Res., 40, 1144-1149 (1980).
- 2) Wang, A. L. and Tew, K. D., Increased glutathione S-transferase activity in a cell line with acquired resistance to nitrogen mustards. Cancer Treat. Rep., 69, 677-682 (1985).
- 3) Pegg, A. E., Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50, 6119-6129 (1990).
- 4) Godwin, A. K., Meister, A., O’Dwyer, P. J., Huang, C. S., Hamilton, T. C., and Anderson, A. E., High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA., 89, 3070-3074 (1992).
- 5) Goto, S., Yoshida, K., Morikawa, T., Urata, Y., Suzuki, K., and Kondo T., Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Cancer Res., 55, 4297-4301 (1995).
- 6) Berhane, K., Widersten, M., Engstrom, A., Kozarich, J. W., and Mannervik, B., Detoxication of base propenals and other α,β-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transrases. Proc. Natl. Acad. Sci. USA, 91, 1480-1484 (1994).
- 7) Sollod, C. C., Jenns, A. E., and Daub, M. E., Cell surface redox potential as a mechanism of defense against photosensitizers in fungi. Appl. Environ. Microbiol., 58, 444-449 (1992).
- 8) Perego, P., Weghe, J. V., Ow, D. W., and Howell, S. B., Role of determinans of cadmium sensitivity in the tolerance of Schizosaccharomyces pombe to cisplatin. Molecul. Pharmacol., 51, 12-18 (1997).
- 9) Martinoia, E., Grill, E., Tommasini, R., Kreuz K., and Amrhein, N., ATP-dependent glutathione S-conjugate ‘export’ pump in the vacuolar membrane of plants. Nature, 364, 247-249 (1993).
- 10) Ishikawa, T., Wright, C. D., and Ishizuka, H., GS-X pump is functionally overexpressed in cis-diamminedichloro-platinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J. Biol. Chem., 269, 29085-29093 (1994).
- 11) Novogrodsky, A., Nehring, R. E. Jr., and Meister, A., Inhibition of amino acid transport into lymphoid cells by the glutamine analog L-2-amino-4-oxo-5-chloropentanoate. Proc. Natl. Acad. Sci. USA, 76, 4932-4935 (1979).
- 12) Fortuniak, A., Zadzinski, R., Bilinski, T., and Bartosz, G., Glutathione depletion in the yeast Saccharomyces cerevisiae. Biochem. Molecul. Biol. Int., 38, 901-910 (1996).
- 13) Andrews, P. A., Murphy, M. P., and Howell, S. B., Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res., 45, 6250-6253 (1985).
- 14) Chen, Z-S., Mutoh, M., Sumizawa, T., Furukawa, T., Haraguchi, M., Tani, A., and Akiyama, S., Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells. Biochem. Biophys. Res. Commn., 236, 586-590 (1997).
- 15) Wickner, R. B., Chromosomal and nonchromosomal mutations affecting the “killer character” of Saccharomyces cerevisiae. Genetics, 76, 423-432 (1974).
- 16) Ohtake, Y. and Okumura, Y., Establishing a high glutathione producing yeast species. Bioscience to Industry (in Japanese), 50, 29-34 (1992).
- 17) Disaia, P. J., Sinkovics, J. G., Rutledge, F. N., and Smith, J. P., Cell-mediated immunity to human malignant cells. Am. J. Obstet. Gynecol. 114, 979-989 (1972).
- 18) Isonishi, S., Ochiai, K., Yasuda, M., Ohkawa, K., and Terashima, Y., Mehcanism-related circumvention of cisplatin resistance in human ovarian carcinoma cells by (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum(II) monohydrate and modulation of its sensitivity by 12-O-tetradecanoylphorbol-13-acetate. Int. J. Oncol., 5, 1309-1314 (1994).
- 19) Kistler, M., Summer, K. H., and Eckardt, F., Isolation of glutathione-deficient mutants of the yeast Saccharomyces cerevisiae. Mutant. Res., 173, 117-120 (1986).
- 20) Ohtake, Y., Satou, A., and Yabuuchi, Y., Isolation and Characterization of Glutathione Biosynthesis-dependent Mutans in Saccharomyces cerevisiae. Agric. Biol. Chem., 54, 3145-3150 (1990).
- 21) Riche, J. P. Jr. and Lang, C. A., The determination of glutathione, cysteine, and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection. Anal. Biochem., 163, 9-15 (1987).
- 22) Miyake, A., δ-Hydroxy-γ-oxo-L-norvaline, a new antitubercular antibiotic (2). synthetic studies. Chem. Pharm. Bull., 8, 1074-1079 (1960).
- 23) Schmidt, U., Stabler, F., and Lieberknecht, A., Stereoselective Synthesis of the Antibiotics (+)-Negamycin and (-)-HON (RI-331). Synthesis, 482-486 (1992).
- 24) Tatsuoka, S., Miyake, A., Hitomi, H., Ueyanagi, J., Iwasaki, H., and Yamaguchi, T., HON, a new antibiotic produced by Streptomyces Akiyoshiensis Nov. sp. J. Antibiot. Ser. A. 14, 39-43 (1961).
- 25) Yamaguchi, H., Uchida, K., Hiratani, T., Nagate, T., Watanabe, N., and Omura, S., RI-331, a new antifungal antibiotic. Ann. N. Y. Acad. Sci., 544, 188-190 (1988).
- 26) Yamaguchi, M., Yamaki, H., Shinoda, T., Tago, Y., Suzuki, H., Nishimura, T., and Yamaguchi, H., The mode of antifungal action of (S) 2-amino-4-oxo-5-hydroxypentanoic acid, RI-331. J. Antibiot. 43, 411-416 (1990).
- 27) Yamaki, H., Yamaguchi, M., Imamura, H., Suzuki, H., Nishimura, T., Saito, H., and Yamaguchi, H., The mechanism of antifungal action of (S)-2-amino-4-oxo-5-hydroxypentanoic acid, RI-331: the inhibition of homoserine dehydrogenase in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun., 168, 837-843 (1990).
- 28) O’Dwyer, P. J., Hamilton, T. C., and Young, R. C., Delection of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results. J. Natl. Cancer Inst., 84, 264-267 (1992).
Full access
5-Hydroxy-4-oxo-L-norvaline Depletes Intracellular Glutathione: a New Modulator of Drug Resistance
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.